Drugs / EPA ethyl esters
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02310022 Comparator | Nov 2014 → May 2015 | hypertriglyceridemia | Matinas Biopharma, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPA ethyl esters | “In this open-label, crossover trial, subjects received MAT9001 and EPA ethyl esters (EPA-EE) in random order.” PMID 28391875 ↗ Oct 2016 |
| Known as | EPA-EE | “In this open-label, crossover trial, subjects received MAT9001 and EPA ethyl esters (EPA-EE) in random order.” PMID 28391875 ↗ Oct 2016 |